Announcements Trials
Browse Landscape

Phase

Phase NA 1Phase 4 1

Status

Terminated 1

Sponsor Class

OTHER_GOV 1

Study Type

Interventional 1

Sponsor

Conditions

Pain, Postoperative 1Breast Neoplasms 1

Interventions

Dexmedetomidine 12Bupivacaine 11Ropivacaine 8Saline Solution 6Morphine 6Injections, Epidural 5Ketamine 4Control Groups 4Acetaminophen 4Sodium Chloride 3Pregabalin 3Dental Occlusion 3Anesthesia, General 3Analgesia, Patient-Controlled 3parecoxib 2Tea 2Surgical Procedures, Operative 2Parapsychology 2Gabapentin 2Anesthetics, Local 2thiamine triphosphorate 1tetraethylpyrazine 1salicylhydroxamic acid 1oxycodone-acetaminophen 1esmolol 1Vitamins 1Transcutaneous Electric Nerve Stimulation 1Thoracic Surgery, Video-Assisted 1Therapeutics 1Tablets 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase NA × Pain, Postoperative × Diclofenac × Clear all
NCT03796403 2020-10-23

Bupivacaine Plus Diclofenac Versus Bupivacaine Alone for Postoperative Pain Relief in Gynecologic Cancer Patients

Department of Medical Services Ministry of Public Health of Thailand

Phase NA Terminated
140 enrolled

Pain, Postoperative

Data powered by HemOnc (CC BY 4.0) Colophon âš¡